CancerResource is a publicly accessible, web‑based database that compiles experimentally validated interactions between anti‑cancer drugs and their molecular targets. The resource is designed to support cancer research, drug discovery, and translational studies by providing curated information on drug–target relationships, associated signaling pathways, and disease relevance.
Purpose and Scope
- Provides a searchable collection of drug–target pairs that have been confirmed through experimental studies, including biochemical assays, cell‑line screens, and clinical investigations.
- Integrates additional contextual data such as the type of cancer in which the interaction has been observed, the mode of action (e.g., inhibition, activation), and links to relevant pathway and functional annotation databases.
Data Curation and Sources
- Entries are manually curated from peer‑reviewed literature and reputable biomedical databases.
- Each record typically includes the drug name (and standard identifiers such as PubChem CID), the target protein (gene symbol, UniProt accession), the interaction type, the experimental evidence supporting the interaction, and a bibliographic reference.
- Where applicable, the resource cross‑references external repositories such as UniProt, PubChem, GeneCards, KEGG, and Reactome to provide comprehensive biological context.
Access and Functionality
- The database is freely available through a web interface that allows users to query by drug name, target gene, cancer type, or pathway.
- Search results can be filtered, sorted, and downloaded in standard formats (e.g., CSV, TSV) for downstream analysis.
- An application programming interface (API) is provided for programmatic access, facilitating integration with bioinformatics pipelines and computational drug‑repurposing workflows.
Applications in Research
- Identification of candidate drugs for repurposing based on shared target profiles across different cancer types.
- Construction of drug‑target interaction networks for systems‑level analyses of oncology therapeutics.
- Validation of computational predictions of drug efficacy by cross‑referencing with experimentally confirmed interactions.
- Support for precision‑medicine initiatives through the linkage of target information to genomic alterations observed in patient cohorts.
Development and Maintenance
- CancerResource was initially described in a peer‑reviewed publication by a consortium of bioinformaticians and cancer biologists (the specific citation details are not provided here).
- The database is maintained by the originating institution(s) and receives periodic updates as new literature becomes available.
Limitations
- Because the resource relies on manual curation, coverage may lag behind the most recent publications, particularly for newly approved therapeutics or emerging molecular targets.
- Users are advised to verify critical information against original experimental reports, especially when employing the data for clinical decision‑making or regulatory submissions.
References
- Primary description of CancerResource: CancerResource: a database of experimentally validated anti‑cancer drug target interactions (journal reference).
- Subsequent citations illustrating its use in network pharmacology and drug‑repurposing studies.
Note: Specific bibliographic details (authors, journal, year) are not provided here due to insufficient encyclopedic information in the source material.